Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sodium, potassium, magnesium, calcium and glucose injection is a multi-component intravenous solution developed by Beijing Minkan Baicao Pharmaceutical Technology. It serves as a balanced electrolyte and carbohydrate source, intended to maintain or restore fluid and electrolyte balance while providing caloric support through glucose. This formulation is typically utilized in clinical settings for patients requiring parenteral fluid therapy, such as those with dehydration, electrolyte deficiencies, or during the perioperative period to support metabolic needs and osmotic stability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium, potassium, magnesium, calcium and glucose injection.